According to Inhibrx's latest financial reports the company's current EPS (TTM) is -3,86 โฌ. In 2022 the company made an earnings per share (EPS) of -3,45 โฌ a decrease over its 2021 EPS that were of -2,05 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -3,82 โฌ | 10.65% |
2022 | -3,45 โฌ | 68.37% |
2021 | -2,05 โฌ | -11.87% |
2020 | -2,33 โฌ | 36.64% |
2019 | -1,70 โฌ |